Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.
2.

Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.

Hartman AL, Bird BH, Towner JS, Antoniadou ZA, Zaki SR, Nichol ST.

J Virol. 2008 Mar;82(6):2699-704. doi: 10.1128/JVI.02344-07. Epub 2008 Jan 16.

4.

dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.

Zinzula L, Esposito F, Pala D, Tramontano E.

Antiviral Res. 2012 Mar;93(3):354-63. doi: 10.1016/j.antiviral.2012.01.005. Epub 2012 Jan 25.

PMID:
22289166
5.

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A.

J Virol. 2003 Jul;77(14):7945-56.

6.

Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli.

Zinzula L, Esposito F, Mühlberger E, Trunschke M, Conrad D, Piano D, Tramontano E.

Protein Expr Purif. 2009 Jul;66(1):113-9. doi: 10.1016/j.pep.2009.02.008. Epub 2009 Feb 20.

PMID:
19233284
7.

Evasion of interferon responses by Ebola and Marburg viruses.

Basler CF, Amarasinghe GK.

J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076. Review.

9.

Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A.

J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.

10.

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF.

Immunol Cell Biol. 2011 Oct;89(7):792-802. doi: 10.1038/icb.2010.169. Epub 2011 Jan 25.

11.

The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.

Bharaj P, Atkins C, Luthra P, Giraldo MI, Dawes BE, Miorin L, Johnson JR, Krogan NJ, Basler CF, Freiberg AN, Rajsbaum R.

J Virol. 2017 Aug 24;91(18). pii: e00833-17. doi: 10.1128/JVI.00833-17. Print 2017 Sep 15.

12.

Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T.

PLoS One. 2010 May 19;5(5):e10719. doi: 10.1371/journal.pone.0010719.

13.

Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.

Feagins AR, Basler CF.

Virology. 2015 Nov;485:145-52. doi: 10.1016/j.virol.2015.07.010. Epub 2015 Aug 6.

14.

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.

Prins KC, Cárdenas WB, Basler CF.

J Virol. 2009 Apr;83(7):3069-77. doi: 10.1128/JVI.01875-08. Epub 2009 Jan 19.

15.

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection.

Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, Rollin PE.

Virology. 2003 Aug 1;312(2):415-24.

16.

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF.

Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.

17.

Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Edwards MR, Liu G, Mire CE, Sureshchandra S, Luthra P, Yen B, Shabman RS, Leung DW, Messaoudi I, Geisbert TW, Amarasinghe GK, Basler CF.

Cell Rep. 2016 Feb 23;14(7):1632-1640. doi: 10.1016/j.celrep.2016.01.049. Epub 2016 Feb 11.

18.

The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Noda T, Kolesnikova L, Becker S, Kawaoka Y.

J Infect Dis. 2011 Nov;204 Suppl 3:S878-83. doi: 10.1093/infdis/jir310.

19.

The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.

Dilley KA, Voorhies AA, Luthra P, Puri V, Stockwell TB, Lorenzi H, Basler CF, Shabman RS.

PLoS One. 2017 Jun 21;12(6):e0178717. doi: 10.1371/journal.pone.0178717. eCollection 2017.

20.

[Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments].

Rudzevich TN, Ternovoĭ VA, Kazachinskaia EI, Razumov IA, Chepurnov AA, Loktev VB, Netesov SV.

Mol Gen Mikrobiol Virusol. 2003;(2):38-40, backcover. Russian.

PMID:
12800775

Supplemental Content

Support Center